Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/804
Name: Drug, bio-affecting and body treating compositions > Involving igg3, igg4, iga, or igy
Description: Subject matter involving immunoglobulin IgG3, IgG4, IgA, or IgY.

Patents under this class:

Patent Number Title Of Patent Date Issued
8609098 Composition for repression of hyperlipidemia and obesity through suppression of intestinal cholesterol absorption Dec. 17, 2013
8440191 Clearance of abnormal IGA1 in IGA1 deposition diseases May. 14, 2013
8420330 Diagnosis and treatment of cardiac troponin 1 (cTn1) autoantibody-mediated heart disease Apr. 16, 2013
7892538 Monovalent ligand of the Fc.alpha.RI receptor as an anti-inflammatory agent Feb. 22, 2011
7713527 Specific avian egg antibodies for disease prevention and improvement of growth performance May. 11, 2010
7514079 Antibodies that specifically bind to neurokinin B Apr. 7, 2009
7311912 Epithelial tissue targeting agent Dec. 25, 2007
6833131 Antivenom immunesera Dec. 21, 2004
6656468 Clostridial toxin disease therapy Dec. 2, 2003
6646108 Process for isolating IgG and IgA Nov. 11, 2003
6613326 Antitoxins and methods for making antitoxins Sep. 2, 2003
6346247 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies Feb. 12, 2002
6287568 Methods relating to immunogenic dextran-protein conjugates Sep. 11, 2001
5827534 Oral dosage composition comprising zonnula occludens toxin and a therapeutic agent for intestinal delivery Oct. 27, 1998
5741489 Passively administered antibody that enhances feed conversion efficiency Apr. 21, 1998
5585098 Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants Dec. 17, 1996
5340923 Methods for making and purifying antivenoms Aug. 23, 1994
5308614 Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones May. 3, 1994
5258177 IgA preparation and process of making the same Nov. 2, 1993
5202422 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use Apr. 13, 1993
5171667 Hybridomas producing monoclonal antibodies to mono-, di- and trifucosylated type 2 chain Dec. 15, 1992
5169627 Oral pharmaceutical composition containing a polyethylene glycol-immunoglobulin G conjugate for reconstitution of secretory immunity and method of reconstituting secretory immunity Dec. 8, 1992
5151266 Use of anionic detergents with conjugates of monoclonal or polyclonal antibodies Sep. 29, 1992
5130127 Human tumor therapy using beta (1-3) glucanlentinan and anti-tumor antibodies Jul. 14, 1992
5091178 Tumor therapy with biologically active anti-tumor antibodies Feb. 25, 1992
5082931 Type II bacterial Fc receptors Jan. 21, 1992
5055559 Anti-melanoma antibody MG-21 for diagnosis and therapy of human tumors Oct. 8, 1991
5004694 Complement-dependent cytolytic anti-Trichomonas vaginalis monoclonal antibodies Apr. 2, 1991
4970299 Monoclonal antibodies selective for prostate cancer Nov. 13, 1990
4965068 Polyvalent hyperimmunoglobulin preparation Oct. 23, 1990
4962188 Recombinant ricin toxin A chain conjugates Oct. 9, 1990
4958009 Anti-human ovarian cancer immunotoxins and methods of use thereof Sep. 18, 1990
4956453 Anti-human ovarian cancer immunotoxins and methods of use thereof Sep. 11, 1990
4938948 Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies Jul. 3, 1990
4894229 Carrier-bound immunogenic determinants and carrier therefor Jan. 16, 1990
4885358 Monoclonal antibodies specific for synthetic glycosphingolipids having abnormal branched structure Dec. 5, 1989
4880913 Process for the preparation of an immunoglobulin which can be administered intravenously and is stable in liquid form Nov. 14, 1989
4876199 Hybridomas producing monoclonal antibodies to mono-, di-, and trifucosylated type 2 chain Oct. 24, 1989
4851511 Monoclonal antibody that specifically binds to disialosyl Le.sup.a Jul. 25, 1989
4844893 EX vivo effector cell activation for target cell killing Jul. 4, 1989
4841024 Purification of antibodies Jun. 20, 1989
4753894 Monoclonal anti-human breast cancer antibodies Jun. 28, 1988
4734279 Combination of immunoglobulins with therapeutic agents Mar. 29, 1988
4731244 Monoclonal antibody therapy Mar. 15, 1988
4698420 Antibody hybrid molecules and process for their preparation Oct. 6, 1987
4550019 Manufacture and use of fowl egg antibodies Oct. 29, 1985
4455296 Hybrid cell lines producing monoclonal antibodies directed against Haemophilus influenzae Jun. 19, 1984
4335099 Employment of enteric coated IgA for hypoproteinemia in intestinal infectious diseases Jun. 15, 1982
3993747 Method for local immunization against dental caries Nov. 23, 1976

  Recently Added Patents
System and method for customized prompting
Catalyst composition with nanometer crystallites for slurry hydrocracking
Bioreactor device, and method and system for fabricating tissues in the bioreactor device
Methods and systems for motion estimation with nonlinear motion-field smoothing
Aggregating completion messages in a sideband interface
Hydroxyl-terminated thiocarbonate containing compounds, polymers, and copolymers, and polyurethanes and urethane acrylics made therefrom
Measurement protocol for a medical technology apparatus
  Randomly Featured Patents
Mobile X-ray apparatus
Absorbent article
Spiral strip acoustic treatment
Combined key ring and extendable, self-defensive baton
System for distributed beamforming for a communication system employing relay nodes
Nonreciprocal circuit element
Connection verification technique
Integrated tabbed note and clip
Reciprocating cylinder engine
High capacitance flexible circuit